NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss drugs. This one added some patients talking about stockpiling compounded semaglutide/tirzepatide, and on Lilly’s latest efforts to block compounding. And yes, it included comments from APC’s Scott Brunner.
Unfortunately the text version is an older story, but you can listen to the Morning Edition piece here: